Infectious Disease Point-of-care (POC) Diagnostics Market Size, Trends, Growth, Opportunities | F. Hoffmann-La Roche Ltd., Cepheid, and Abbott Laboratories

The infectious disease point-of-care (POC) diagnostics market was valued at USD 15.81 billion in 2022 and is projected to grow from USD 15.21 billion in 2023 to USD 12.46 billion by 2030, recording a CAGR of -2.8% during the forecast period.

The Infectious Disease Point-of-Care (POC) Diagnostics Market is experiencing remarkable growth due to the increasing need for rapid, accurate, and accessible diagnostic solutions. As global healthcare systems evolve, the demand for portable and efficient POC diagnostics continues to rise, driven by advancements in technology and a heightened focus on early detection of infectious diseases.

𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂'𝗿𝗲 𝗠𝗶𝘀𝘀𝗶𝗻𝗴: 𝗚𝗲𝘁 𝗮 𝗙𝗿𝗲𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 (𝗣𝗗𝗙) 𝗦𝗮𝗺𝗽𝗹𝗲: https://www.fortunebusinessinsights.com/enquiry/sample/infectious-disease-point-of-care-poc-diagnostics-market-104307

𝗞𝗲𝘆 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁

In January 2023, Cipla Inc. launched its CE IVD-approved point-of-care testing device, Cippoint. This innovative device is designed to diagnose both non-communicable and infectious diseases, representing a significant step forward in healthcare accessibility and diagnostic precision.

𝗧𝗼𝗽 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝘂𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗣𝗢𝗖 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗠𝗮𝗿𝗸𝗲𝘁

• F. Hoffmann-La Roche Ltd (Switzerland)
• Thermo Fisher Scientific Inc. (U.S.)
• Abbott Laboratories (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• BD (U.S.)
• bioMérieux SA (France)
• Cardinal Health, Inc. (U.S.)
• Cepheid (U.S.)
• Trinity Biotech (Ireland)
• Quidel Corporation (U.S.)
• Bio-Rad Laboratories Inc. (U.S.)

𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀 𝗮𝗻𝗱 𝗥𝗲𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀

𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀

The infectious disease POC diagnostics market is propelled by the following key drivers:

• Increasing prevalence of infectious diseases, including emerging viral infections.
• Growing demand for rapid and accurate diagnostic solutions to curb disease outbreaks.
• Technological advancements in molecular diagnostics, enhancing detection capabilities.
• Rising awareness about the importance of early diagnosis to improve treatment outcomes.
• Expanding adoption of POC devices in remote and resource-limited settings.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀

Despite its growth potential, the market faces several challenges:

• High costs associated with advanced POC diagnostic devices.
• Limited technical expertise in operating complex devices in remote areas.
• Stringent regulatory frameworks affecting product approval and market entry.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝘃𝗲𝗿𝗮𝗴𝗲

The comprehensive report on the infectious disease POC diagnostics market provides detailed insights into emerging trends, key market segments, and competitive dynamics. It offers a holistic view of the factors influencing growth and the challenges shaping the market landscape.

𝗙𝗼𝗿 𝗙𝘂𝗹𝗹 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝘃𝗲𝗿𝗮𝗴𝗲 𝗩𝗶𝘀𝗶𝘁:https://www.fortunebusinessinsights.com/infectious-disease-point-of-care-poc-diagnostics-market-104307

𝗠𝗮𝗿𝗸𝗲𝘁 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲

The market is highly competitive, with major players investing in R&D and strategic collaborations to enhance their product portfolios. Companies such as Abbott Laboratories and bioMérieux SA are focusing on technological innovations, while others like Thermo Fisher Scientific emphasize expanding their geographic footprint.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀

𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀: 𝗧𝗵𝗲 𝗟𝗲𝗮𝗱𝗶𝗻𝗴 𝗦𝗲𝗴𝗺𝗲𝗻𝘁

The molecular diagnostics segment is expected to dominate the market, driven by its accuracy, sensitivity, and ability to detect a wide range of pathogens. These diagnostics are particularly vital for detecting complex infections and managing disease outbreaks effectively.

𝗢𝘁𝗵𝗲𝗿 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀

Other segments, such as immunoassays and lateral flow assays, also play a critical role in the market, offering rapid and cost-effective diagnostic solutions suitable for large-scale testing scenarios.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀

The infectious disease POC diagnostics market exhibits diverse growth patterns across regions:

• North America: A leading region due to robust healthcare infrastructure and widespread adoption of advanced diagnostic technologies.
• Europe: Growth is driven by increasing investments in healthcare and rising awareness of early diagnostics.
• Asia-Pacific: A rapidly growing market, fueled by high disease prevalence and government initiatives to improve healthcare access.
• Middle East & Africa: The market is expanding due to increasing focus on healthcare advancements in underdeveloped regions.

𝗙𝘂𝘁𝘂𝗿𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗰𝗼𝗽𝗲

• Development of portable, AI-powered POC diagnostics for enhanced precision.
• Integration of POC devices with telemedicine platforms for remote disease management.
• Focus on affordability to cater to resource-limited settings.
• Expansion of molecular diagnostics to address a broader spectrum of infectious diseases.
• Collaborative efforts between public and private sectors to improve market penetration.

𝗖𝗼𝗻𝗰𝗹𝘂𝘀𝗶𝗼𝗻

The Infectious Disease Point-of-Care (POC) Diagnostics Market is poised for exponential growth, driven by technological innovations, rising healthcare awareness, and increasing demand for rapid diagnostics. Industry leaders are capitalizing on these trends, making significant advancements to enhance diagnostic accuracy and accessibility. With a promising future ahead, this market is set to transform global healthcare landscapes.

For comprehensive insights, visit the Infectious Disease POC Diagnostics Market Report.

𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗔𝗰𝗰𝗼𝗿𝗱𝗶𝗻𝗴 𝗧𝗼 𝗬𝗼𝘂𝗿 𝗖𝗼𝗻𝘃𝗲𝗻𝗶𝗲𝗻𝗰𝗲: https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/infectious-disease-point-of-care-poc-diagnostics-market-104307

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝘀:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.:+1 833 909 2966 (Toll-Free)
U.K.: +44 808 502 0280 (Toll-Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.